Together, these findings uncover Rhbdl2 as an immune checkpoint that constrains macrophage-driven enhanced regeneration, with vast implications for inflammatory disease, fibrosis, and tumor-immune interactions. This evidence concerns the gene RHBDL2 and neoplasm.